Suppr超能文献

普罗帕酮对病态窦房结综合征患者的电生理效应

[Electrophysiologic effects of propafenone in patients with sinus node dysfunction].

作者信息

Alboni P, Filippi L, Pirani R, Preziosi S, Paparella N

出版信息

G Ital Cardiol. 1984 Apr;14(4):297-303.

PMID:6735023
Abstract

The electrophysiologic effects of intravenously administered Propafenon (1,5 mg/kg) were evaluated in 16 patients (mean age: 62,1 +/- 11 years) with sinus node dysfunction, shown by sinus bradycardia or intermittent sino-atrial block. The variations of sinus cycle length were not statistically significant (NS), (1137,1 +/- 244,9 msec versus 1191,9 +/- 321,1 msec). In one patient sinus rate markedly decreased from 36 to 28 beats/min. In 2 patients the cycle length of a junctional rhythm was comparable before and after drug administration; in both patients the rate of the junctional rhythm decreased and in one markedly (from 39 to 32 beats/min). Sinoatrial conduction time increased in 4 patients and decreased in 6. The variations were not statistically significant (223,8 +/- 76 msec versus 230,6 +/- 75,9 msec). In one patient the sinoatrial conduction time which was normal during the control study, could not be evaluated after Propafenon due to the appearance of a retrograde block between the atrium and the sinus node. Maximum corrected sinus node recovery time was prolonged by the drug in 9 patients and shortened in 5. In 2 patients the sinus node recovery time was prolonged to about 10 sec. The mean value of corrected sinus node recovery time increased from 883,6 +/- 995,8 msec to 1820,5 +/- 2894 msec (NS). Propafenon significantly prolonged the effective refractory period and the functional refractory period of the atrium, as well as the A-H, H-V and QRS intervals, the A-V node functional refractory period, the relative refractory period of His-Purkinje system and the ventricular effective refractory period.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在16例(平均年龄:62.1±11岁)表现为窦性心动过缓或间歇性窦房阻滞的窦房结功能障碍患者中,评估了静脉注射普罗帕酮(1.5mg/kg)的电生理效应。窦性周期长度的变化无统计学意义(NS)(1137.1±244.9毫秒对1191.9±321.1毫秒)。1例患者窦性心率从36次/分显著降至28次/分。2例患者交界性心律的周期长度在用药前后相当;2例患者交界性心律的速率均下降,其中1例显著下降(从39次/分降至32次/分)。4例患者窦房传导时间增加,6例患者窦房传导时间减少。变化无统计学意义(223.8±76毫秒对230.6±75.9毫秒)。1例患者在对照研究期间窦房传导时间正常,注射普罗帕酮后由于心房与窦房结之间出现逆行阻滞而无法评估。9例患者用药后最大校正窦房结恢复时间延长,5例患者缩短。2例患者窦房结恢复时间延长至约10秒。校正窦房结恢复时间的平均值从883.6±995.8毫秒增加至1820.5±2894毫秒(无统计学意义)。普罗帕酮显著延长了心房的有效不应期和功能不应期,以及A-H、H-V和QRS间期、房室结功能不应期、希氏-浦肯野系统的相对不应期和心室有效不应期。(摘要截断于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验